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AGE OF THE CARTILAGE TISSUE DETERMINES ITS MATRIX
DEPOSITION CAPABILITIES
N. Ahmed, D. Taylor, R. Kandel. SLRI, Toronto, ON, Canada
Purpose: Proper selection of cell source is a persisting problem
for cartilage tissue engineering because it is difﬁcult to attain
sufﬁcient number of chondrocytes from sparsely cellular cartilage tissue.
Chondrocytes can be increased in number by cell culture however they
readily dedifferentiate towards ﬁbroblast like and lose their chondrocytic
phenotype. Previously we have shown that co-culture of these cultured
passaged dedifferentiated chondrocytes with small numbers of primary
chondrocytes induces redifferentiation in dedifferentiated cells. Here we
show that the age affects ability of primary chondrocytes to induce
redifferentiation in passaged cells.
Methods: Cell preparation: Human fetal (17 weeks), human adult articular
(18–60 yrs.) and bovine articular cartilage (young 6–9 months, old
24–36 months) were harvested and chondrocytes were isolated by
sequential enzymatic digestion. Co-culture: the passaged dedifferentiated
cells were mixed with primary chondrocytes at ratio of 4:1 and co-
cultured on Millicell™ ﬁlter inserts which allow for 3D culture in 20%
FBS containing DMEM-HG. Analysis: After 4 weeks the newly formed
tissue was characterized and compared with bovine and human primary
chondrocyte cultures. Histological qualitative assessment was done by
Toluidine Blue staining. Proteoglycan accumulation was quantitatively
determined by dimethylmethylene blue dye-binding assay. Values were
normalized to total DNA content determined by Hoechst 33258 dye
binding assay. Gene expression was quantiﬁed by qPCR. Statistics: Results
were expressed as mean ± SD of 3 independent experiments and
signiﬁcance was determined by one-way ANOVA.
Results: To determine the effect of age on the ability of chondrocytes
to accumulate proteoglycans and induce redifferentiation chondrocytes
from older and younger cows were compared with each other after
4 weeks of in vitro culture (Fig. 1).
After 4 weeks when visualized under microscope after Toluidine blue
staining more young cells appeared to be alive and surrounded by
newly deposited cartilaginous matrix. Dimethylmethylene blue assay
showed that the proteoglycan content of tissue formed by co-cultured
of young primary chondrocytes and old passaged cells at 4 weeks
was signiﬁcantly higher than tissue formed by the co-culture with old
primary chondrocytes. qPCR showed higher gene expression of type
II collagen, aggrecan, and SOX9. passged cells alone failed to produce
cartilaginous matrix regardless of age or species difference.
Conclusion: We conclude that young primary chondrocytes produce
factors which affect the cartilaginous matrix deposition capabilities of
dedifferentiated cells. Further studies on human fetal chondrocytes are
in progress.




Fig.1. Bovine primary chondrocytes cultured for 4 weeks in 3D culture
and stained with Toluidine Blue. (A) Young chondrocytes (B) Old
chondrocytes.
477
NEW ALGINATE-CHITOSAN HYDROGEL BEADS WITH
ANTI-INFLAMMATORY AND ANABOLIC EFFECTS ON HUMAN
CHONDROCYTES
F. Oprenyeszk1, M. Mathy-Hartert1, C. Sanchez1, J-E. Dubuc2, V. Maquet3,
Y. Henrotin1. 1BCRU, Univ. of Lie`ge, Lie`ge, Belgium; 2Orthopaedic Dept.,
Cliniques Univ. St Luc, Brussels, Belgium; 3KitoZyme SA, Parc industriel des
Haut-Sarts, Herstal, Belgium
Purpose: Today, here is no treatment to cure osteoarthritis (OA) or to
delay effectively its progression. Current treatments are mainly based
on the alleviation of painful symptoms but are unable to restore the
cartilage lining the joint. The repair of cartilage lesion still remains a great
challenge for orthopaedic surgeons. The development of new scaffolds
for tissue engineering is a promising approach. Herein, we report the
effects of alginate-chitosan hydrogel (AC) beads on the metabolism of
chondrocytes.
Methods: Human chondrocytes were isolated from OA cartilage obtained
from knee joints after replacement surgery and then cultured for
21 days either in AC beads or in alginate (A) beads. AC beads were
prepared using ultra-pure chitosan (KiOmedine-CsU from KitoZyme)
with molecular weight of 40 K (AC40) or 20 K (AC20) and alginate
from Sigma. The two polymer solutions were prepared separately before
being mixed together. Cells were added to the polymer mixture and the
cell-containing beads prepared by precipitation in a calcium chloride
solution. The chondrocytes embedded in the beads (0.5 to 1 x 105
cells/bead) were then cultured for 21 days in DMEM supplemented with
10% foetal bovine serum, 10 mM HEPES, 100 U/ml penicillin, 100mg/ml
streptomycin, 2 mM L-glutamine, 50mg/ml ascorbic acid and 20mg/ml
proline. Histological staining of the parafﬁne embedded beads was
performed with hematoxylin/eosin (HE). Cell viability was determined
by quantifying the amount of lactate deshydrogenase (LDH) released in
the culture medium. Interleukin (IL)-6 and -8, Matrix MetalloProteinase
(MMP)-3 and aggrecan (AGG) were measured by speciﬁc sandwich
enzyme-linked immunoabsorbent assays (ELISA). A spectrophotometric
method based upon the Griess reaction was used to quantify nitric oxide
(NO) product.
Results: AC and A beads were successfully prepared. Histological analysis
of AC beads showed a homogeneous distribution of chitosan trabeculae
in the alginate matrix and the presence of chondrocytes in contact
with chitosan trabeculae (Figure 1). LDH level remained below the
limit of detection over the culture duration suggesting that the AC
had no cytotoxic effect. By comparison with cells cultured in A beads,
chondrocytes cultured in AC40 or AC20 beads produced signiﬁcantly
higher amounts of AGG but lower levels of MMP-3, NO, IL-6 and IL-8
factors (Table 1).
Fig. 1. (A) Histology of chondrocytes (arrows) cultured in AC20 during
21 days. (B) Gross observation of AC20 beads.
Table 1. AGG, MMP-3, NO, IL-6 and IL-8 production of chondrocyte
in AC40 and AC20 beads. Results are presented as % of production of
chondrocytes in A beads.
AGG MMP-3 NO IL-6 IL-8
AC40 217.68±72.24∗∗∗ 59.04±30.04∗∗ 46.82±6.21∗∗∗ 19.17±14.8∗∗∗ 17.16±3.37∗∗∗
AC20 154.27±15.23∗∗ 21.69±16.64∗∗∗ 42.12±20.20∗∗∗ 12.67±2.58∗∗∗ 6.12±3.37∗∗∗
Results expressed as mean±SEM of 3 independent experiments performed with cartilage specimens coming
from different donors. Each experimental condition was performed in triplicate. Comparison of mean values
was performed by Student t parametric analysis. ∗∗∗p < 0.001, ∗∗p < 0.01. Production of cells in AC beads was
signiﬁcantly different than production of cells in A beads.
Conclusions: AC beads reduce the production of inﬂammatory and
catabolic mediators by OA chondrocytes and promotes the synthesis of
cartilage-speciﬁc matrix components. These particular effects indicate
that AC beads are a potential carrier for cell transplantation, and
particularly to repair cartilage defects.
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REPAIRING ARTICULAR CARTILAGE WITH HUMAN AMNIOTIC
MEMBRANE EPITHELIAL AND MESENCHYMAL STEM CELLS
E. Muin˜os-Lopez1, S.M. Diaz-Prado1,2, T. Hermida-Go´mez1, E. Rendal-
Va´zquez3, I. Fuentes-Boquete1,2, F.J. De Toro1,2, F.J. Blanco1. 1INIBIC-CHUAC,
A Corun˜a, Spain; 2INIBIC-Univ. of A Corun˜a, A Corun˜a, Spain; 3Cryobiology
Unit. CHUAC, A Corun˜a, Spain
Purpose: There is an increasing interest about human amniotic
membrane (HAM) for its use in the ﬁeld of regenerative medicine. Two
kinds of progenitor cells can be remove from the amniotic membrane,
the amniotic mesenchymal stromal cells (hAMSC) and amniotic epithelial
cells (hAEC). Both cell types are capable to differentiate towards three
germinal cell lines. It has large advantages over the others sources of
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progenitor cells. The aim of this study is to determinate the useful of
the hAMSC and the hAEC on regenerating human joint cartilage in an in
vitro model.
Methods: HAM was used as support for the culture of hAMSCs or hAECs.
Focal injuries in human joint cartilage biopsies were done. Later, a pellet
of cells (hAMSCs or hAECs, depending on the repair model developed)
was implanted into the focal defects of cartilage. HAM, with the cells
grown on it, was placed in direct contact with the cartilage surface to be
repaired. These implants were cultured in DMEM+10% FBS for 8 weeks.
The repair tissues were analyzed by histological and histochemistry
analysis considering the ICRS macroscopic evaluation of cartilage repair.
Results: hAMSCs and hAECs cultured on HAM and transplanted onto
focal injuries of cartilage penetrated into the nearby surface of the
chondral defect. The Hematoxylin and Eosin staining showed that
hAMSC or hAECs pellet ﬁlled the chondral defect. There was a good
integration between the repair tissue and native cartilage. Type II
collagen and aggrecan stainings of repair tissue were slightly positive on
the extracellular matrix, and positive inside the cytoplasm of the cells.
The safranin O staining expressed the presence of proteoglycans. Finally,
type I collagen stainings were weak or totally negative (Figure 1A). We
realized an ICRS macroscopic evaluation of cartilage repair to compare
both kinds of progenitor cells in the in vitro model. hAMSCs displayed
better degree of defect repair, greatest integration to border zone and,
in general, higher repair assessment (Figure 1B).
Conclusions: We get reduce the area of the defect with quality
integration. The morphology of the repair tissue showed a
ﬁbrocartilaginous appearance and a high cellularity. hAMSCs showed
better results considering the ICRS macroscopic evaluation of cartilage
repair.
Fig. 1. (A) Histological and histochemistry analysis of hAMSCs and hAECs
in vitro models; (B) Table with hAMSCs and hAECs means assessment
considering the ICRS macroscopic evaluation of cartilage repair.
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THE EFFECT OF HYDROXYAPATITE MICROPARTICLES ON THE
DIFFERENTIATION OF MESENCHYMAL STEM CELLS SEEDED INTO
COLLAGEN GELS
F. Laydi1,2, G. Cauchois1,2, J-F. Stoltz1,2, N. de Isla1,2. 1Nancy Universite´,
Faculty of Med., Vandoeuvre-le`s-Nancy, France; 2CNRS UMR 7561,
Vandoeuvre-le`s-Nancy, France
Purpose: In vitro differentiation of mesenchymal stem cells (MSC) for
osteo-articular tissue engineering involves speciﬁc differentiation factors
like cytokines and growth factors. Moreover, scaffolds are often used,
principally hydrogels, to culture MSC. In this work we studied the
inﬂuence of the hydrogel composition on MSC differentiation without
using speciﬁc differentiation factors.
Methods: Hydrogels were prepared by mixing rat tail type I collagen
(ColI), hydroxyapatite (Hap) microparticles at different sizes (150mm-
large, 80mm-medium and 30mm-small) and bone marrowMSCs to obtain
a ﬁnal concentration of 3mg/ml colI; 1mg/ml, 2mg/ml or 3mg/ml of Hap
and 5.105 cell/ml. pH was adjusted to 7 and the mixture was distributed
on each well of 96-well culture plates. Gels without Hap were used
as controls. The behavior of MSC over 21 days of culture was studied:
viability by confocal microscopy, gel contraction, cell metabolism, cell
proliferation and transcription factors speciﬁc of different differentiation
pathways (Sox-9 for chondrogenesis, Runx-2 for osteogenesis, PPAR-g for
adipogenesis) by PCR.
Results: Images obtained by confocal microscopy showed that type I
collagen/hydroxyapatite hydrogels are biocompatible with the MSC. For
all the conditions essayed, there were few dead cells, all over the culture
period. Moreover, we observed that the behavior of the cells follows an
evolution in two phases: the ﬁrst, until 14 days in culture supports the
cellular proliferation and the contraction of the gel while the second
period, from day 14 to day 21, involves a cellular commitment of the
cells in differentiation pathways. While Hap concentration or particle size
inside gels did not inﬂuence cell viability or proliferation, its presence
inﬂuences cell differentiation. The gene expression analysis shows a
signiﬁcant increase of the chondrogenic transcription factor Sox-9 for
the cells culture on gels containing Hap. Moreover, differences were
found according to particle size or concentration.
Conclusions: The results suggest that MSC differentiation can be
modulated by hydrogels composition. That will be useful for tissue
engineering because to avoid the use of cytokines or growth factors
could facilitate therapeutic applications.
Therapy – Non-Pharmacologic
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EFFECTS OF ORAL ADMINISTRATION OF HYAL-JOINT® FOR THE
TREATMENT OF KNEE OSTEOARTHRITIS WITH SYNOVIAL EFFUSION:
A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
I. Mo¨ller1, D. Martinez-Puig2, C. Chetrit2. 1Inst. Poal de Reumatologia,
Barcelona, Spain; 2BIOIBERICA S.A., Palafolls, Spain
Purpose: To evaluate the clinical efﬁcacy of (Hyal-Joint®) in patients with
moderate to severe osteoarthritis of the knee coursing with persistent
knee pain and joint effusion.
Methods: 70 adults with moderate to severe knee OA (grades II-III
of K-L criteria) and presenting lateral or longitudinal synovial effusion
(>4mm at the suprapatellar recess) were recruited between March and
August 2010 in a prospective, double-blind, placebo-controlled trial with
a parallel design. Patients were randomly assigned to receive either Hyal-
Joint® (Bioiberica, Palafolls, Spain; n = 35) or Placebo (PCT; n =35) at a
dose of 80mg/d during a period of 3 months. The primary outcome was
the course of synovial effusion assessed monthly in the suprapatellar
recess using ultrasonography (US) equipment with a high frequency
linear array. The maximal synovial thickness and effusion depth were
measured in mm using the longitudinal scale according to a standard
published protocol. The secondary outcome was the pain intensity
assessed weekly using the Huskisson’s visual analogue scale (VAS).
Results: At baseline the mean synovial effusion was similar between
treatment groups (6.85 and 6.16mm for Hyal-Joint® and placebo groups
respectively). Synovial effusion was progressively reduced in both groups
during the experimental period, reaching a lower value in the Hyal-
Joint® group (2.72mm) in comparison with the placebo group (3.15mm)
at 3 months. Pain intensity was also similar between groups at baseline
(6.4 and 6.5 cm for for Hyal-Joint® and placebo groups respectively).
Pain perception was progressively reduced from baseline until the end
of the trial in both groups. From week 9 until week 12 pain reduction
was more pronounced in group Hyal-Joint® group in comparison with
placebo. In the Hyal-Joint® group, at week 9, pain intensity was 50%
reduced from basal values, while the reduction was only of 32% for
the placebo group. Differences between treatment groups in both pain
intensity and synovial effusion were clinically relevant and tended to
reach statistical signiﬁcance.
Conclusions: Our results suggest that the use of Hyal-Joint® for the
management of the knee osteoarthritis coursing with synovial effusion
is safe and well tolerated, tending to show clinical beneﬁts in pain
remission and helping to control synovial inﬂammation.
